Sever Pharmaceuticals

Sever Pharmaceuticals is a specialized Contract Development and Manufacturing Organization (CDMO) that provides end-to-end services for highly potent and complex pharmaceutical products. Headquartered in Malmö, Sweden, the company was established as an independent entity following a carve-out from Ferring Pharmaceuticals and its integration with QPharma. They specialize in the development and manufacture of high-potency drugs, long-acting injectables, and polymer-based drug delivery systems such as vaginal rings and implants. Their capabilities span from initial formulation development and clinical trial material production to full-scale commercial manufacturing and packaging. Sever Pharmaceuticals serves a global client base, focusing on therapeutic areas such as oncology and women's health where specialized containment and complex delivery technologies are required. The company operates state-of-the-art facilities that comply with international GMP standards to ensure the highest quality for their partners.